The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Aardvark Therapeutics Inc shares valued at $43,200 were purchased by Sun Nelson on Dec 11 ’25. At $14.40 per share, Sun Nelson acquired 3,000 shares. The insider’s holdings grew to 108,484 shares worth approximately $1.55 million following the completion of this transaction.
Also, Lee Tien-Li purchased 7,000 shares, netting a total of over 101,395 in proceeds. Following the buying of shares at $14.48 each, the insider now holds 1,551,613 shares.
Before that, Lee Tien-Li had added 10,000 shares to its account. In a trade valued at $96,624, the Chief Executive Officer bought Aardvark Therapeutics Inc shares for $9.66 each. Upon closing the transaction, the insider’s holdings increased to 10,000 shares, worth approximately $22.01 million.
As published in their initiating research note from Oppenheimer on December 23, 2025, Aardvark Therapeutics Inc [AARD] has been an Outperform and the price target has been revised to $35. Analysts at William Blair started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid December. As of December 03, 2025, Raymond James has initiated its “Strong buy” rating for AARD. Earlier on November 07, 2025, BTIG Research initiated its rating. Their recommendation was “a Buy” for AARD stock.
Analyzing AARD Stock Performance
On last trading session, Aardvark Therapeutics Inc [NASDAQ: AARD] rose 0.78% to $14.26. The stock’s lowest price that day was $14.0, but it reached a high of $14.6092 in the same session. During the last five days, there has been a surge of approximately 7.87%.
Support And Resistance Levels for Aardvark Therapeutics Inc (AARD)
According to the 24-hour chart, there is a support level at 13.97, which, if violated, would cause prices to drop to 13.68. In the upper region, resistance lies at 14.58. The next price resistance is at 14.90. RSI (Relative Strength Index) is 59.91 on the 14-day chart, showing neutral technical sentiment.
Is Aardvark Therapeutics Inc subject to short interest?
Stocks of Aardvark Therapeutics Inc saw a sharp rise in short interest on 2025-11-28 jumping by 0.46 million shares to 1.3 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 0.84 million shares. A jump of 35.38% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 8.44 of the overall float, the days-to-cover ratio (short ratio) jumped to 8.44.
Which companies own the most shares of Aardvark Therapeutics Inc (AARD)?
In terms of Aardvark Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 24 in the next 12 months, up nearly 69.61% from the previous closing price of $14.15. Analysts anticipate Aardvark Therapeutics Inc stock to reach 35 by 2025, with the lowest price target being 18. On September 29, 2025, Stifel assigned a price target of “a Buy” to the stock and initiated coverage with a $24.
